Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

Clinical trial NCT05352750 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05352750
Sponsor: Sonnet BioTherapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Soft Tissue Sarcoma Adult

Start date: 2022-04-20
Primary completion: 2026-06-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.